Mature pipeline of biopharmaceuticals for rare diseases. Government funding for biodefense business.
Overview
Soligenix is a two-segment business. They have a biotherapeutics rare disease segment focused on cancer, cancer supportive care and inflammation and a separate vaccine/biodefense segment of business funded entirely by the U.S. government, focused on medical countermeasures for military and civilian use.
Categories: PROFILES
